Quarterly Results

  • Company Name :
ERIS Lifesciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 540596
  • NSE Symbol:
  • ERIS
  • P/E(TTM):
  • 67.68
  • ISIN Demat:
  • INE406M01024
  • Div & Yield%:
  • 0.50
  • EPS(TTM):
  • 21.44
  • Book Value(₹):
  • 230.54
  • Market Cap(₹Cr.):
  • 20,103.27
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 306.78 637.58 567.90
Excise Duty 0.00 0.00 0.00
Net Sales 306.78 637.58 567.90
Other Operating Income 8.51 12.92 10.74
Other Income 25.07 23.59 22.68
Total Income 340.36 674.09 601.32
Total Expenditure 252.61 353.62 362.32
PBIDT 87.75 320.47 239.00
Interest 45.20 46.50 45.14
PBDT 42.55 273.97 193.86
Depreciation 38.66 39.30 37.60
Tax 0.51 40.91 27.17
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.29 44.19 29.10
Reported Profit After Tax 3.09 149.57 99.99
Extra-ordinary Items -13.87 0.00 0.00
Adjusted Profit After Extra-ordinary item 16.96 149.57 99.99
EPS (Unit Curr.) 0.23 10.98 7.34
EPS (Adj) (Unit Curr.) 0.23 10.98 7.34
Calculated EPS (Unit Curr.) 0.23 10.98 7.34
Calculated EPS (Adj) (Unit Curr.) 0.23 10.98 7.34
Calculated EPS (Ann.) (Unit Curr.) 0.91 43.93 29.37
Calculated EPS (Adj) (Ann.) (Unit Curr.) 0.91 43.93 29.37
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 13.62 13.62 13.62
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 28.60 50.26 42.08
PBDTM(%) 13.87 42.97 34.14
PATM(%) 1.01 23.46 17.61